Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 619

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Integrated PET/CT: Current Applications and Future Directions

von Schulthess, Gustav K., Steinert, Hans C., Hany, Thomas F.·2006·Radiology
DOI 10.1148/radiol.2382041977
Open this paper in CoChat — free account

Abstract

For the past 5 years, combined positron emission tomography (PET) and computed tomography (CT), or PET/CT, has grown because the PET portion provides information that is very different from that obtainable with other imaging modalities. However, the paucity of anatomic landmarks on PET images makes a consistent "hardware fusion" to anatomic cross-sectional data extremely useful. Clinical experience indicates a single direction: Addition of CT to PET improves specificity foremost, but also sensitivity, and the addition of PET to CT adds sensitivity and specificity in tumor imaging. Thus, PET/CT is a more accurate test than either of its individual components and is probably also better than side-by-side viewing of images from both modalities. The synergistic advantage of adding CT is that the attenuation correction needed for PET can also be derived from the CT data, an advantage not obtainable by integrating PET and magnetic resonance imaging. This makes PET/CT 25%-30% faster than PET alone with standard attenuation-correction methods, leading to higher patient throughput and a more comfortable examination, which typically last 30 minutes or less. Fluorodeoxyglucose (FDG) PET/CT appears to provide relevant information in the staging and therapy monitoring of many tumors, including lung carcinoma, mesothelioma, colorectal cancer, lymphoma, melanoma, and many others, with the notable exception of prostatic cancer. For prostatic cancer, choline derivatives may become useful radiopharmaceuticals. The published literature on the applications of FDG PET/CT in oncology is still limited, but several well-designed studies have demonstrated the benefits of PET/CT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1148/radiol.2382041977

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 77

  1. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology.J Nucl Med2000; 41: 1369–1379.
  2. 10.1148/radiol.2252011568 · DOI · Paper page
  3. 10.1007/s00259-002-0796-3 · DOI · Paper page
  4. Dizendorf E, Hany TF, Buck A, von Schulthess GK, Burger C. Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies.J Nucl Med2003;44:732–738.
  5. 10.1007/s00259-002-1070-4 · DOI
  6. Nehmeh SA, Erdi YE, Kalaigian H, et al. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT.J Nucl Med2003;44:1940–1944.
  7. 10.1148/radiol.2263011732 · DOI · Paper page
  8. 10.1007/s00330-002-1564-2 · DOI · Paper page
  9. 10.1007/s00259-002-1055-3 · doi:10.1007/s00259-002-1055-3
  10. 10.1007/s00259-001-0698-9 · DOI
  11. 10.1056/NEJMoa022136 · DOI · Paper page
  12. 10.1200/JCO.2004.08.120 · DOI · Paper page
  13. Keidar Z, Haim N, Guralnik L, et al. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.J Nucl Med2004;45:1640–1646.
  14. 10.1007/s00261-003-0163-2 · doi:10.1007/s00261-003-0163-2
  15. 10.1007/s00259-004-1593-y · DOI
  16. 10.1148/radiol.2292021598 · DOI · Paper page
  17. 10.1016/S0360-3016(03)00346-8 · DOI · Paper page
  18. 10.1016/S0003-4975(00)01817-8 · doi:10.1016/s0003-4975(00)01817-8
  19. 10.1097/00000658-198908000-00001 · DOI · Paper page
  20. 10.1148/radiology.206.3.9494497 · DOI · Paper page
  21. Kantorova I, Lipska L, Belohlavek O, Visokai V, Trubac M, Schneiderova M. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making.J Nucl Med2003;44:1784–1788.
  22. 10.1067/msy.2001.116919 · doi:10.1067/msy.2001.116919
  23. Goldberg RM, Fleming TR, Tangen CM, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection.Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med1998;129:27–35. · DOI · Paper page
  24. Flamen P, Stroobants S, Van Cutsem E, et al. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer.J Clin Oncol1999;17:894–901. · DOI · Paper page
  25. 10.1200/JCO.20.2.388 · doi:10.1200/jco.20.2.388 · Paper page
  26. 10.1016/0969-8051(96)00080-7 · DOI · Paper page
  27. Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma.J Nucl Med2003;44:1797–1803.
  28. 10.1148/radiol.2323031065 · doi:10.1148/radiol.2323031065
  29. 10.1097/01.sla.0000146145.69835.c5 · DOI · Paper page
  30. 10.1097/00000658-200103000-00003 · DOI
  31. 10.1056/NEJM200104053441404 · DOI · Paper page
  32. 10.1007/s00259-004-1633-7 · doi:10.1007/s00259-004-1633-7
  33. Antoch G, Kanja J, Bauer S, et al. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors.J Nucl Med2004;45:357–365.
  34. 10.1023/A:1008486928190 · DOI · Paper page
  35. 10.1148/radiology.203.3.9169707 · DOI · Paper page
  36. 10.1007/s002590050275 · DOI · Paper page
  37. 10.1093/annonc/mdf664 · doi:10.1093/annonc/mdf664
  38. 10.3816/CLM.2002.n.012 · doi:10.3816/clm.2002.n.012
  39. 10.1046/j.1365-2141.2003.04617.x · DOI
  40. 10.1002/cncr.10336 · DOI · Paper page
  41. 10.2214/ajr.182.6.1821579 · doi:10.2214/ajr.182.6.1821579
  42. 10.1148/radiol.2323030985 · DOI
  43. Kitagawa Y, Nishizawa S, Sano K, et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.J Nucl Med2003;44:198–206.
  44. 10.1148/radiol.2311030271 · doi:10.1148/radiol.2311030271
  45. 10.1148/radiol.2241011254 · DOI
  46. Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat (“USA-Fat”): description on 18F-FDG PET/CT.J Nucl Med2003;44:170–176.
  47. Kamel EM, Thumshirn M, Truninger K, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results.J Nucl Med2004;45:1804–1810.
  48. 10.1016/j.rcl.2004.07.006 · DOI
  49. Rogers JW, Greven KM, McGuirt WF, et al.Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys2004;58:694–697. · doi:10.1016/s0360-3016(03)01625-0
  50. 10.1007/s00259-003-1408-6 · DOI
  51. Yeretsian RA, Blodgett TM, Branstetter BF 4th, Roberts MM, Meltzer CC. Teflon-induced granuloma: a false-positive finding with PET resolved with combined PET and CT.AJNR Am J Neuroradiol2003;24(6):1164–1166.
  52. Torizuka T, Tamaki N, Inokuma T, et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.J Nucl Med1995;36:1811–1817.
  53. Torizuka T, Tamaki N, Inokuma T, et al. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.J Nucl Med1994;35:1965–1969.
  54. 10.1097/01.sla.0000172095.97787.84 · DOI · Paper page
  55. Yancik R. Ovarian cancer: age contrasts in incidence, histology, disease stage at diagnosis, and mortality.Cancer1993;71:517–523. · DOI · Paper page
  56. 10.1148/radiol.2332031800 · doi:10.1148/radiol.2332031800
  57. Pannu HK, Cohade C, Bristow RE, Fishman EK, Wahl RL. PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation.Abdom Imaging2004;29:398–403. · DOI
  58. Picchio M, Sironi S, Messa C, et al. Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment.Q J Nucl Med2003;47:77–84.
  59. 10.1002/1097-0142(19920601)69:11<2796::AID-CNCR2820691127>3.0.CO;2-O · doi:10.1002/1097-0142(19920601)69:11<2796::aid-cncr2820691127>3.0.co;2-o
  60. 10.1016/0090-8258(90)90085-Y · DOI · Paper page
  61. Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix.J Clin Oncol2001;19:3745–3749. · DOI · Paper page
  62. 10.1016/j.ygyno.2004.05.053 · doi:10.1016/j.ygyno.2004.05.053
  63. Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT.J Nucl Med2004;45:266–271.
  64. 10.1007/s00259-004-1536-7 · doi:10.1007/s00259-004-1536-7
  65. Dizendorf E, Baumert B, von Schulthess GK, Luetolf UM, Steinert HC. The impact of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) on planning of radiotherapy [in Russian].Ter Arkh2001;73:11–14.
  66. 10.1016/j.ijrobp.2003.10.044 · DOI · Paper page
  67. Namdar M, Hany TF, Koepfli P, et al. Integrated PET/CT for the assessment of coronary artery disease: a feasibility study.J Nucl Med2005;46:930–935.
  68. 10.1046/j.1464-410X.2003.04297.x · doi:10.1046/j.1464-410x.2003.04297.x
  69. 10.1111/j.1464-410X.2003.04692.x · doi:10.1111/j.1464-410x.2003.04692.x
  70. 10.1148/radiol.2352040494 · doi:10.1148/radiol.2352040494
  71. 10.1016/S0969-8051(03)00097-0 · doi:10.1016/s0969-8051(03)00097-0
  72. 10.1148/radiology.220.2.r01au25373 · DOI · Paper page
  73. 10.1007/s00259-003-1338-3 · DOI
  74. de Winter F, van de Wiele C, Vogelaers D, de Smet K, Verdonk R, Dierckx RA. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections.J Bone Joint Surg Am2001; 83-A:651–660. · doi:10.2106/00004623-200105000-00002
  75. 10.1016/S1536-1632(03)00035-0 · DOI
  76. 10.1148/radiol.2262011939 · DOI
  77. 10.1148/radiol.2312021596 · doi:10.1148/radiol.2312021596

Cited by

See all 619

Metadata

Authors
von Schulthess, G. K., Steinert, H. C., & Hany, T. F.
Venue
Radiology
Publisher
Radiological Society of North America (RSNA)
Published
2006-02
Volume
238
Issue
2
Pages
405-422
ISSN
  • 0033-8419 (ISSN-L)
  • 1527-1315
DOI
10.1148/radiol.2382041977
OpenAlex
W2020657588
Cited by
619
References
1
FWCI
48.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrated PET/CT: Current Applications and Future Directions. https://app.cochat.ai/papers/10.1148/radiol.2382041977
The paper
von Schulthess, G. K., Steinert, H. C., & Hany, T. F. (2006). Integrated PET/CT: Current Applications and Future Directions. Radiology. https://doi.org/10.1148/radiol.2382041977

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.